Questões de Concurso Comentadas sobre inglês
Foram encontradas 19.468 questões
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387331
Inglês
Read and answer.
“Falisha and I had a horrible fight last night, but this morning we made it up with each other.”
We can say that
“Falisha and I had a horrible fight last night, but this morning we made it up with each other.”
We can say that
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387329
Inglês
Read and answer.
“Petro made fun of Jonathan’s clothing style.”
We can assume that
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387326
Inglês
Mark the alternative that completes the blank.
“Janice found a shirt ______ at her room.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387325
Inglês
Complete the blank.
“A teacher _____ had an accident last weekend, so we don’t have classes this afternoon.”
“A teacher _____ had an accident last weekend, so we don’t have classes this afternoon.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387324
Inglês
Complete the sentence with the best alternative.
“That old machine cleans ________!”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387323
Inglês
Choose the best alternative to complete the sentence.
“The girls climbed that tree _____.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387322
Inglês
Mark the best alternative to complete the blank.
“Phoebe hurt ______ last game, then, she might not play tomorrow.”
“Phoebe hurt ______ last game, then, she might not play tomorrow.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387320
Inglês
Choose the correct alternative.
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387318
Inglês
Find the incorrect alternative.
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387317
Inglês
Find an alternative to complete the blank.
“Zoey ____ helping Drake with his homework.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387316
Inglês
Mark an alternative to complete the sentence.
“Elephants _____ supposed to stay in the forest.”
“Elephants _____ supposed to stay in the forest.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387315
Inglês
Choose an alternative to complete the sentence.
“Hiking ________ me to feel better."
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387314
Inglês
Find the alternative that completes the blanks.
“Kylie ____ classical music, her friends ______.”
“Kylie ____ classical music, her friends ______.”
Ano: 2017
Banca:
CONSESP
Órgão:
Prefeitura de Ribeirão Bonito - SP
Prova:
CONSESP - 2017 - Prefeitura de Ribeirão Bonito - SP - Professor Educação Básica II - Inglês |
Q1387313
Inglês
Mark the alternative that best completes the blank.
“The Kardashiars __ waiting for you.”
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335084
Inglês
Texto associado
Read the text below and answer the following question based on it.
Is gene editing ethical?
Gene editing is the modification of DNA sequences in living
cells. What that means in reality is that researchers can
either add mutations or substitute genes in cells or
organisms.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
The ethical issue involving gene editing used in
embryos or prior stages
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335083
Inglês
Texto associado
Read the text below and answer the following question based on it.
Is gene editing ethical?
Gene editing is the modification of DNA sequences in living
cells. What that means in reality is that researchers can
either add mutations or substitute genes in cells or
organisms.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
As for the new CRISPR/Cas9 system technique,
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335082
Inglês
Texto associado
Read the text below and answer the following question based on it.
Is gene editing ethical?
Gene editing is the modification of DNA sequences in living
cells. What that means in reality is that researchers can
either add mutations or substitute genes in cells or
organisms.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
Gene editing holds the key to preventing or treating debilitating genetic diseases, giving hope to millions of people around the world. Yet the same technology could unlock the path to designing our future children, enhancing their genome by selecting desirable traits such as height, eye color, and intelligence.
While this concept is not new, a real breakthrough came 5 years ago when several scientists saw the potential of a system called CRISPR/Cas9 to edit the human genome.
CRISPR/Cas9 allows us to target specific locations in the genome with much more precision than previous techniques. This process allows a faulty gene to be replaced with a non-faulty copy, making this technology attractive to those looking to cure genetic diseases.
The technology is not foolproof, however. Scientists have been modifying genes for decades, but there are always trade-offs. We have yet to develop a technique that works 100 percent and doesn't lead to unwanted and uncontrollable mutations in other locations in the genome.
In a laboratory experiment, these so-called off-target effects are not the end of the world. But when it comes to gene editing in humans, this is a major stumbling block.
The fact that gene editing is possible in human embryos has opened a Pandora's box of ethical issues.
Here, the ethical debate around gene editing really gets off the ground.
When gene editing is used in embryos — or earlier, on the sperm or egg of carriers of genetic mutations — it is called germline gene editing. The big issue here is that it affects both the individual receiving the treatment and their future children.
This is a potential game-changer as it implies that we may be able to change the genetic makeup of entire generations on a permanent basis.
One could state that
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335081
Inglês
Texto associado
Read the text below and answer the following question based on it.
Indian surgeons separate twins joined at the head
Two-year-old Jaga and Kalia underwent 16 hours of surgery, and are now in the intensive care unit, doctors said.
A team of 30 doctors carried out the surgery - the first of its kind in India - at a state-run hospital.
The boys were born with shared blood vessels and brain tissues, a very rare condition that occurs once in about three million births.
The director of the All India Institute of Medical Sciences, Randeep Guleria, told the Press Trust of India that the "next 18 days would be extremely critical to ascertain the success of the surgery".
The twins, hailing from a village in eastern Orissa state, were joined at the head - a condition known as craniopagus.
Even before the operation they had defeated the odds; craniopagus occurs in one in three million births, and 50% of those affected die within 24 hours, doctors say.
"Both the children have other health issues as well. While Jaga has heart issues, Kalia has kidney problems," neurosurgeon A K Mahapatra said.
"Though initially Jaga was healthier, now his condition has deteriorated. Kalia is better," he added.
Doctors said the most challenging job after the separation was to "provide a skin cover on both sides of the brain for the children as the surgery had left large holes on their heads".
"If the twins make it, the next step will be reconstructing their skulls," plastic surgeon Maneesh Singhal said.
The first surgery was performed on 28 August when the doctors created a bypass to separate the shared veins that return blood to the heart from the brain.
A team of 30 doctors carried out the surgery - the first of its kind in India - at a state-run hospital.
The boys were born with shared blood vessels and brain tissues, a very rare condition that occurs once in about three million births.
The director of the All India Institute of Medical Sciences, Randeep Guleria, told the Press Trust of India that the "next 18 days would be extremely critical to ascertain the success of the surgery".
The twins, hailing from a village in eastern Orissa state, were joined at the head - a condition known as craniopagus.
Even before the operation they had defeated the odds; craniopagus occurs in one in three million births, and 50% of those affected die within 24 hours, doctors say.
"Both the children have other health issues as well. While Jaga has heart issues, Kalia has kidney problems," neurosurgeon A K Mahapatra said.
"Though initially Jaga was healthier, now his condition has deteriorated. Kalia is better," he added.
Doctors said the most challenging job after the separation was to "provide a skin cover on both sides of the brain for the children as the surgery had left large holes on their heads".
"If the twins make it, the next step will be reconstructing their skulls," plastic surgeon Maneesh Singhal said.
The first surgery was performed on 28 August when the doctors created a bypass to separate the shared veins that return blood to the heart from the brain.
Adaptado de: <http://www.bbc.com/news/world-asia-india-41772987>Acessado em 27 de outubro de 2017.
One of the greatest difficulties after the surgery
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335080
Inglês
Texto associado
Read the text below and answer the following question based on it.
Indian surgeons separate twins joined at the head
Two-year-old Jaga and Kalia underwent 16 hours of surgery, and are now in the intensive care unit, doctors said.
A team of 30 doctors carried out the surgery - the first of its kind in India - at a state-run hospital.
The boys were born with shared blood vessels and brain tissues, a very rare condition that occurs once in about three million births.
The director of the All India Institute of Medical Sciences, Randeep Guleria, told the Press Trust of India that the "next 18 days would be extremely critical to ascertain the success of the surgery".
The twins, hailing from a village in eastern Orissa state, were joined at the head - a condition known as craniopagus.
Even before the operation they had defeated the odds; craniopagus occurs in one in three million births, and 50% of those affected die within 24 hours, doctors say.
"Both the children have other health issues as well. While Jaga has heart issues, Kalia has kidney problems," neurosurgeon A K Mahapatra said.
"Though initially Jaga was healthier, now his condition has deteriorated. Kalia is better," he added.
Doctors said the most challenging job after the separation was to "provide a skin cover on both sides of the brain for the children as the surgery had left large holes on their heads".
"If the twins make it, the next step will be reconstructing their skulls," plastic surgeon Maneesh Singhal said.
The first surgery was performed on 28 August when the doctors created a bypass to separate the shared veins that return blood to the heart from the brain.
A team of 30 doctors carried out the surgery - the first of its kind in India - at a state-run hospital.
The boys were born with shared blood vessels and brain tissues, a very rare condition that occurs once in about three million births.
The director of the All India Institute of Medical Sciences, Randeep Guleria, told the Press Trust of India that the "next 18 days would be extremely critical to ascertain the success of the surgery".
The twins, hailing from a village in eastern Orissa state, were joined at the head - a condition known as craniopagus.
Even before the operation they had defeated the odds; craniopagus occurs in one in three million births, and 50% of those affected die within 24 hours, doctors say.
"Both the children have other health issues as well. While Jaga has heart issues, Kalia has kidney problems," neurosurgeon A K Mahapatra said.
"Though initially Jaga was healthier, now his condition has deteriorated. Kalia is better," he added.
Doctors said the most challenging job after the separation was to "provide a skin cover on both sides of the brain for the children as the surgery had left large holes on their heads".
"If the twins make it, the next step will be reconstructing their skulls," plastic surgeon Maneesh Singhal said.
The first surgery was performed on 28 August when the doctors created a bypass to separate the shared veins that return blood to the heart from the brain.
Adaptado de: <http://www.bbc.com/news/world-asia-india-41772987>Acessado em 27 de outubro de 2017.
The surgery to separate the twin brothers
Ano: 2017
Banca:
Cepros
Órgão:
CESMAC
Prova:
Cepros - 2017 - CESMAC - Prova de Medicina-2018.1-1° DIA- PROVA TIPO 1 |
Q1335079
Inglês
Texto associado
Read the text below and answer the following
question based on it.
Virtual reality may help relieve phantom limb pain.
In a recent study, patients experienced reduced phantom
limb pain after playing an augmented reality car racing
game that required them to move the missing limb. Phantom
limb pain is the experience of pain in a limb after it has been
amputated.
The underlying mechanisms responsible for phantom limb pain remain unclear. However, it appears that it may arise as a consequence of abnormal neural circuitry in central areas of the brain.
Limited success has been achieved with mirror therapy in which reflections of the unaffected limb can be used to create the illusion that the amputated limb is moving.
The underlying mechanisms responsible for phantom limb pain remain unclear. However, it appears that it may arise as a consequence of abnormal neural circuitry in central areas of the brain.
Limited success has been achieved with mirror therapy in which reflections of the unaffected limb can be used to create the illusion that the amputated limb is moving.
The latest study has taken the mirror therapy concept a step
further; patients visualise and 'move' the phantom limb using
augmented reality—‘phantom motor execution’. It was
conducted in 14 patients who had been experiencing
phantom limb pain since the amputation of an arm.
Sensors that could detect muscular activity were attached to the stump of the missing arm. The signals received by these sensors were then used to produce an image of an active arm on a computer screen.
Patients were trained to use these signals to control the virtual arm, drive a virtual race car around a track and to copy the movements of an arm on screen with their phantom movements. After twelve 2-hour treatment sessions, the patients underwent follow-up interviews 1, 3 and 6 months later.
Based on the patients' ratings, the intensity, quality, and frequency of pain had reduced by 50% after the treatment.
At the start of the study, 12 patients reported feeling constant pain whereas only 6 did 6months after the treatment. However, one patient thought that there was not a considerable difference in the levels of phantom pain before and after treatment.
Sensors that could detect muscular activity were attached to the stump of the missing arm. The signals received by these sensors were then used to produce an image of an active arm on a computer screen.
Patients were trained to use these signals to control the virtual arm, drive a virtual race car around a track and to copy the movements of an arm on screen with their phantom movements. After twelve 2-hour treatment sessions, the patients underwent follow-up interviews 1, 3 and 6 months later.
Based on the patients' ratings, the intensity, quality, and frequency of pain had reduced by 50% after the treatment.
At the start of the study, 12 patients reported feeling constant pain whereas only 6 did 6months after the treatment. However, one patient thought that there was not a considerable difference in the levels of phantom pain before and after treatment.
Adaptado de: <https://www.news-medical.net/news/20161202/Virtual-reality-may-help-relieve-phantom-limb-pain.aspx?utm_source=TrendMD&utm_medium=cpc&utm_> (Acessado em 11 de
outubro de 2017).
The experiment can be said to have been
Conheça nossos planos